This site uses cookies.

Methotrexate (MTX) is used to treat psoriasis, a chronic inflammatory skin disease. 2013;71 Suppl 1:S5-8.

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice.

Unable to load your delegates due to an error Arch Dermatol, 108 (1973), pp. the site you are agreeing to our use of cookies. Regulatory T cells (Tregs) and effector T (Teff) cells were isolated from the blood of patients with psoriasis and healthy controls. This paper reviews the published research on methotrexate's mechanism of action in psoriasis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centersInhibition of cytokine production by methotrexate. Please check you selected the correct society from the list and entered the user name and password you use to log in to your society website.Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiencesMethotrexate induces differentiation of human keratinocytesMethotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexateMethotrexate induces apoptotic cell death in human keratinocytesComparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assayThe changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatmentExpression of p53 protein before and after PUVA treatment in psoriasisCyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatmentAdenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cellsMethotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skinMethotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured human umbilical vein endothelial cellsAltered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapyInhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexateLocalization of endothelial proliferation and microvascular expansion in active plaque psoriasisLack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexateInhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasisIn vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cellsThe anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion moleculesThe antiinflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen speciesLow dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic linesAntiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reactionDifferential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritisMethotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppressionMethotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cellsHighly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluidT cell derived cytokines in psoriatic arthritis synovial fluidsMethotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritisModulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Weinstein GD, Goldfaden G, Frost P. 78. Silverchair Information Systems

Studies published with English abstracts between January 1970 and December 2006 identified in MEDLINE with the keywords methotrexate, psoriasis and mechanism were reviewed. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centersInhibition of cytokine production by methotrexate.

This site uses cookies. Epub 2013 Feb 22.Drug Saf. New login is not successful because the max limit of logins for this user account has been reached.Login failed.

1990 Nov;40(5):697-712. doi: 10.2165/00003495-199040050-00005.Schwartz PM, Barnett SK, Atillasoy ES, Milstone LM.Proc Natl Acad Sci U S A. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice.

New login is not successful because the max limit of logins for this user account has been reached.Login failed. This site uses cookies. All rights reserved.

For more information view the Long before the advent of the biologic agents, methotrexate was the gold standard for the treatment of moderate to severe psoriasis. Low-dose MTX is also effective in treatment of psoriatic arthritis. 3 Mechanism of Action. By continuing to browse Epub 2013 Feb 22.Drug Saf. A favourable efficacy and safety profile has been established for MTX in a large number of clinical trials, as well as in common practice.

Mechanism of action of methotrexate in psoriasis Methotrexate in rheumatoid arthritis.

1973;246(3):231-5. doi: 10.1007/BF00595423.Drugs. Please enable it to take advantage of the complete set of features! For more information view the Long before the advent of the biologic agents, methotrexate was the gold standard for the treatment of moderate to severe psoriasis. 2014 Jul-Aug;105(6):583-9. doi: 10.1016/j.ad.2012.11.017.